| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |